MedTrace Logo

The Effect of Dietary Intervation on Endothelial Glycocalyx in COVID-19 Patients.

NCT05185934 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-05-16

No results posted yet for this study

Summary

The food supplement Endocalyx is considered to support the endothelial glycocalyx integrity by supplying sulfated polysaccharides, anti-oxidant enzymes and additional substrates for glycocalyx synthesis. The investigators will study the effect of Endocalyx on endothelial, vascular and left ventricular myocardial function in patients with COVID-19 infection.

Conditions

Interventions

DIETARY_SUPPLEMENT

Food supplement Endocalyx

Patients with COVID-19 infection will be randomized to receive food supplement Endocalyx for 4 months.

DIETARY_SUPPLEMENT

Placebo

Patients with COVID-19 infection will be randomized to receive placebo for 4 months.

Sponsors & Collaborators

  • University of Athens

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2023-11-01
Completion
2024-01-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05185934 on ClinicalTrials.gov